+37.2%
GSK vs ADVB
-96.8%
+134.0%
-22.4%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | ADVB | Excess | Alpha |
|---|---|---|---|---|
| 1D | +0.5% | -23.6% | +24.1% | +0.4% |
| 7D | +1.1% | +27.8% | -26.6% | +1.4% |
| 30D | +6.3% | -50.8% | +57.1% | +6.0% |
| 3M | +1.8% | -70.5% | +72.3% | +1.3% |
| 6M | +1.7% | -46.7% | +48.4% | +1.0% |
| YTD | +6.5% | -56.7% | +63.2% | +5.9% |
| 1Y | +9.5% | -71.8% | +81.3% | +10.0% |
| All | +37.2% | -96.8% | +134.0% | +49.9% |
Cumulative growth
Daily Returns
Daily percentage return beside ADVB.
Daily Out/Under-Performance
Portfolio return minus ADVB return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × ADVB return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded ADVB wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling